CLIMARA 100 PATCH Canada - anglais - Health Canada

climara 100 patch

bayer inc - estradiol (estradiol hemihydrate) - patch - 100mcg - estradiol (estradiol hemihydrate) 100mcg - estrogens

INSTANYL SOLUTION Canada - anglais - Health Canada

instanyl solution

takeda canada inc - fentanyl (fentanyl citrate) - solution - 50mcg - fentanyl (fentanyl citrate) 50mcg - opiate agonists

INSTANYL SOLUTION Canada - anglais - Health Canada

instanyl solution

takeda canada inc - fentanyl (fentanyl citrate) - solution - 200mcg - fentanyl (fentanyl citrate) 200mcg - opiate agonists

INSTANYL SOLUTION Canada - anglais - Health Canada

instanyl solution

takeda canada inc - fentanyl (fentanyl citrate) - solution - 100mcg - fentanyl (fentanyl citrate) 100mcg - opiate agonists

CYCLESSA desogestrel and ethinyl estradiol États-Unis - anglais - NLM (National Library of Medicine)

cyclessa desogestrel and ethinyl estradiol

aspen global inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.1 mg

KIMIDESS- desogestrel and ethinyl estradiol kit États-Unis - anglais - NLM (National Library of Medicine)

kimidess- desogestrel and ethinyl estradiol kit

par pharmaceutical - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - kimidess® is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. table ii: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, united states.    % of women experiencing an unintended pregnancy within the first year of use   % of women continuing use at one year 3 adapted from hatcher et al., 1998, ref#1. 1 among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience

CYCLESSA desogestrel and ethinyl estradiol États-Unis - anglais - NLM (National Library of Medicine)

cyclessa desogestrel and ethinyl estradiol

organon usa inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.1 mg

PIMTREA-  desogestrel/ethinyl estradiol and ethinyl estradiol  kit États-Unis - anglais - NLM (National Library of Medicine)

pimtrea- desogestrel/ethinyl estradiol and ethinyl estradiol kit

northstar rx llc - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - pimtrea™ (desogestrel/ethinyl estradiol and ethinyl estradiol) tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. adapted from hatcher et al., 1998, ref#1. 1 among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. 2 among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accidental pregnancy durin

AZURETTE desogestrel/ethinyl estradiol and États-Unis - anglais - NLM (National Library of Medicine)

azurette desogestrel/ethinyl estradiol and

watson pharma, inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3) - desogestrel 0.15 mg

CAZIANT TRIPHASIC REGIMEN- desogestrel and ethinyl estradiol États-Unis - anglais - NLM (National Library of Medicine)

caziant triphasic regimen- desogestrel and ethinyl estradiol

remedyrepack inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.1 mg - caziant (desogestrel and ethinyl estradiol tablets) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and implants, depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. % of women experiencing an unintended pregnancy within the first year of use % of women continuing use at one year * method typical use † perfect use ‡ (1) (2) (3) (4) chance § 85 85 spermicides ¶ 26 6 40 periodic abstinence 25 63 calendar 9 ovulation method 3 sympto-thermal # 2 post-ovulation 1 withdrawal 19 4 cap Þ parous women 40 26 42 nulliparous women 20 9 56 sponge parous women 40 20 42 nulliparous women 20 9 56 diaphragm Þ 20 6 56 condom